Matches in Nanopublications for { ?s ?p "[Fifty-four patients with Ph-negative MPN (including 21 essential thrombocythemia [ET], 21 polycythemia vera [PV], 7 primary myelofibrosis, and 5 unclassified MPN) who had progressed to AML (n = 26) or MDS (n = 28) were treated with azacitidine in a patient-named program.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_assertion description "[Fifty-four patients with Ph-negative MPN (including 21 essential thrombocythemia [ET], 21 polycythemia vera [PV], 7 primary myelofibrosis, and 5 unclassified MPN) who had progressed to AML (n = 26) or MDS (n = 28) were treated with azacitidine in a patient-named program.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_provenance.
- NP390467.RA7b8RRBnZMOiTQfp0qG1gt204QW3SLWgdWc0M6SwTXmY130_assertion description "[Fifty-four patients with Ph-negative MPN (including 21 essential thrombocythemia [ET], 21 polycythemia vera [PV], 7 primary myelofibrosis, and 5 unclassified MPN) who had progressed to AML (n = 26) or MDS (n = 28) were treated with azacitidine in a patient-named program.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390467.RA7b8RRBnZMOiTQfp0qG1gt204QW3SLWgdWc0M6SwTXmY130_provenance.
- NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_assertion description "[Fifty-four patients with Ph-negative MPN (including 21 essential thrombocythemia [ET], 21 polycythemia vera [PV], 7 primary myelofibrosis, and 5 unclassified MPN) who had progressed to AML (n = 26) or MDS (n = 28) were treated with azacitidine in a patient-named program.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953914.RAXZhWlmkmKjsxAkRSGkW6VPFCBJ61d_t-gvhF9z42IfI130_provenance.
- NP618133.RAF8PimenJhBWbYAu4CkYia-tguqOzTkvQsUCEmwZyqXk130_assertion description "[Fifty-four patients with Ph-negative MPN (including 21 essential thrombocythemia [ET], 21 polycythemia vera [PV], 7 primary myelofibrosis, and 5 unclassified MPN) who had progressed to AML (n = 26) or MDS (n = 28) were treated with azacitidine in a patient-named program.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618133.RAF8PimenJhBWbYAu4CkYia-tguqOzTkvQsUCEmwZyqXk130_provenance.
- NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_assertion description "[Fifty-four patients with Ph-negative MPN (including 21 essential thrombocythemia [ET], 21 polycythemia vera [PV], 7 primary myelofibrosis, and 5 unclassified MPN) who had progressed to AML (n = 26) or MDS (n = 28) were treated with azacitidine in a patient-named program.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828888.RAYQxzxEczr9xxB--GXJ671S27QTH5gs1vxyyEvT7ZUY8130_provenance.